Search Results

Keyword:neutron

Russian enterprise develops borated polyethylene material for neutron radiation protection

Russian enterprise develops borated polyethylene material for neutron radiation protection

A neutron radiation protection material developed by Russian company NPO Gelar has obtained relevant certification. The material, named Polikeramoplast-PB, is a borated polyethylene that resembles ordinary gray or black plastic sheets in appearance, but its protective performance derives from the combination of hydrogen and boron. According to reports, the hydrogen in the material effectively moderates fast neutrons, reducing the likelihood of subsequent secondary reactions, while the boron helps absorb moderated neutrons. In contrast, traditional heavy metal materials used for gamma-ray shielding are not suitable for standalone neutron protection, as heavy atomic nuclei have limited attenuation effects on neutrons. The material can be used in radiation therapy room protection systems and combined with lead...

2026-08-19

Russian Segment of ISS Adjusts BTN-M2 Equipment Configuration, Continues Neutron and Gamma Radiation Observations

Russian Segment of ISS Adjusts BTN-M2 Equipment Configuration, Continues Neutron and Gamma Radiation Observations

On August 13, 2026, during the ISS-75 expedition mission, Russian cosmonauts Pyotr Dubrov and Anna Kikina performed configuration adjustments to the BTN-M2 scientific equipment inside the Nauka module of the Russian Segment of the International Space Station. Figure 1. Profiles of gamma rays (energies below 500 keV, black curve), 511 keV photons from electron-positron annihilation (green curve), and high-energy neutrons (red curve) detected by the BTN-M2 instrument aboard the ISS on July 30–31, 2026. Red arrows indicate enhanced gamma-ray flux during the solar proton event (SPE) as the ISS passed over high-latitude regions of the Earth...

2026-08-18

U.S. FRIB Secures Contract from Naval Nuclear Laboratory to Develop Quantum-Classical Hybrid Nuclear Reaction Calculation Methods

U.S. FRIB Secures Contract from Naval Nuclear Laboratory to Develop Quantum-Classical Hybrid Nuclear Reaction Calculation Methods

A research project at the Facility for Rare Isotope Beams (FRIB) at Michigan State University, led by Dean Lee, Professor of Physics at FRIB, Professor in the Department of Physics and Astronomy at Michigan State University, and Head of the Theoretical Nuclear Science Department at FRIB, has received one-year contract support from the Naval Nuclear Laboratory. The laboratory is managed by Fluor Marine Propulsion. The project will study how to combine quantum computers with classical computers to improve the accuracy of predictions for neutron interactions with matter. This also represents the first phase of a five-year plan aimed at developing and evaluating new computational tools for nuclear science. In nuclear physics research, accurately predicting how neutrons interact with atomic nuclei...

2026-08-18

Neutron and X-ray tomography reveal hydrogen-rich regions in Martian meteorite "Black Beauty"

Neutron and X-ray tomography reveal hydrogen-rich regions in Martian meteorite "Black Beauty"

An international team of researchers from Denmark, Sweden, and Switzerland recently conducted a three-dimensional non-destructive analysis of a slice of the Martian meteorite NWA 7034 "Black Beauty" using neutron tomography and X-ray tomography, discovering macroscopic hydrogen-rich regions within it. The study suggests that these hydrogen-rich features provide evidence of early water-rock interactions on Mars. The findings have been published in Geophysical Research Letters. Black Beauty is a brecciated meteorite from Mars that was ejected into space by an impact event and eventually landed in the Sahara Desert in Morocco. Weighing approximately 320 grams, the meteorite contains material up to 4.48 billion years old, making it one of the oldest known Martian crustal fragments...

2026-08-17

South Korea's domestically developed lunar radiation detector to travel to the Moon aboard NASA commercial lunar lander

South Korea's domestically developed lunar radiation detector to travel to the Moon aboard NASA commercial lunar lander

The Korea AeroSpace Administration (KASA) announced on August 17 that the Lunar Space Radiation Detector (LVRAD), independently developed by South Korea, will be mounted on a lander under NASA's Commercial Lunar Payload Services (CLPS) program to conduct observations of the radiation environment on the lunar south pole surface. The two sides signed the relevant implementation agreement on August 14. Under the agreement, KASA plans to complete the development of the flight model of the detector by next year and deliver the equipment to the United States in accordance with the NASA lunar lander mission schedule. NASA will be responsible for integrating the Korean-developed detector onto the commercial lunar lander and supporting its operation and data transmission on the lunar surface after launch. LVRAD consists of...

2026-08-17

Russia's SKIF Synchrotron Radiation Facility Hailed as a Milestone for Russian Science

Russia's SKIF Synchrotron Radiation Facility Hailed as a Milestone for Russian Science

On August 13, Russian President Vladimir Putin visited the Koltsovo Science City in Novosibirsk to learn about the operating principles of the Siberian Circular Photon Source (SKIF), a shared-use center. This center is the first facility in a network of modern synchrotron radiation sources being built in Russia, with construction efforts incorporated into the national development program for synchrotron and neutron research and related research infrastructure, covering the period through 2030 and beyond. It was reported that SKIF, with its high-brightness, high-intensity X-ray beams, can serve high-level research in fields such as chemistry, physics, materials science, biology, geology, archaeology, and paleontology. Officials also noted that...

2026-08-14

Idaho National Laboratory's Hot Fuel Examination Facility Named U.S. Nuclear Historic Landmark

Idaho National Laboratory's Hot Fuel Examination Facility Named U.S. Nuclear Historic Landmark

The American Nuclear Society (ANS) recently designated the Hot Fuel Examination Facility (HFEF) at Idaho National Laboratory (INL) as a Nuclear Historic Landmark. Since becoming operational in 1975, the facility has conducted post-irradiation examination of nuclear fuel and materials, and continues to support research on advanced reactors, commercial nuclear fuel, and related energy security. HFEF is located within the Materials and Fuels Complex (MFC) at Idaho National Laboratory and houses the largest inert-atmosphere hot cell in the United States dedicated to nuclear materials research. The hot cell operates in an argon environment and features approximately 4-foot-thick shielding walls, enabling remote, non-destructive, and high-precision examination of highly irradiated fuel and material samples while reducing worker radiation exposure.

2026-08-13

China's First Qualification for Radiation Health Testing and Evaluation of BNCT Equipment Approved

China's First Qualification for Radiation Health Testing and Evaluation of BNCT Equipment Approved

Recently, the Beijing Municipal Health Commission, in accordance with the "Administrative Measures for Radiation Health Technical Service Institutions" (Guoweiban ZhiJian Fa [2026] No. 1), organized experts to conduct on-site reviews of two qualification expansion applications submitted by the National Center for Occupational Safety and Health under the National Health Commission. The projects include performance testing and evaluation of Boron Neutron Capture Therapy (BNCT) equipment and thyroid iodine-131 testing. During the review process, the expert panel conducted a comprehensive examination of the center's management system, personnel allocation, instruments and equipment, and technical capabilities related to radiation health testing and evaluation through document review, technical inquiries, on-site practical operations, and simulated demonstrations...

2026-08-12

Australia's OPAL Multipurpose Reactor Marks 20 Years of Operation: Supporting Nuclear Medicine, Industrial Silicon Irradiation, and Neutron Science

Australia's OPAL Multipurpose Reactor Marks 20 Years of Operation: Supporting Nuclear Medicine, Industrial Silicon Irradiation, and Neutron Science

The OPAL multipurpose reactor at the Lucas Heights campus of the Australian Nuclear Science and Technology Organisation (ANSTO), located south of Sydney, has marked the 20th anniversary of achieving first criticality. On August 12, 2006, OPAL achieved a self-sustaining controlled nuclear chain reaction, marking the facility's transition from the construction phase to the scientific operations phase. ANSTO stated that over the past 20 years, OPAL has become one of Australia's key nuclear science infrastructures, serving multiple fields including medicine, industry, and scientific research. OPAL is not a power reactor and is not used for electricity generation. According to available information, Australian federal law and relevant state and territory legislation prohibit the construction of nuclear power reactors, fuel fabrication, and waste disposal facilities. Unlike power reactors used for...

2026-08-12

Fuse Energy Technologies Corp. Reports FAETON-X Single-Shot D-D Fusion Neutron Yield of 1.27×10¹²

Fuse Energy Technologies Corp. Reports FAETON-X Single-Shot D-D Fusion Neutron Yield of 1.27×10¹²

Fuse Energy Technologies Corp., headquartered in California, USA, announced on August 11 that its megajoule-class dense plasma focus device FAETON-X measured a peak neutron yield of (1.27±0.27)×10¹² neutrons per shot in a single D-D fusion experiment. The company stated that this is one of the highest single-shot fusion neutron yields publicly recorded by a commercial fusion enterprise, and the first to reach the 10¹² order of magnitude. FAETON-X is a megajoule-class pulsed-power fusion system developed by Fuse, designed as a single-pulse flash neutron source, serving pulsed-power fusion R&D and...

2026-08-12

China Bio-Pharma: Enters Cooperation Agreement with Stella Pharma on Boron Neutron Therapy Drug

China Bio-Pharma: Enters Cooperation Agreement with Stella Pharma on Boron Neutron Therapy Drug

China Bio-Pharma Holdings Limited announced on August 12 that the company, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd., and Japan's Stella Pharma Corporation signed a legally binding Master Cooperation Agreement on August 11, 2026, to jointly advance the development and commercialization of Steboronine in China. Steboronine is described in the announcement as the world's first approved boron neutron therapy drug, applied in Boron Neutron Capture Therapy (BNCT). Under the agreement, the cooperation between the two parties is divided into a development phase and a commercialization phase. During the development phase, the cooperation aims to leverage real-world data, real-world evidence, and real-world studies generated by the China Bio-Pharma Group to facilitate Stella Pharma in obtaining and maintaining, as soon as possible, marketing approval from China's National Medical Products Administration (NMPA) for Steboronine for the treatment of head and neck cancer; after Stella Pharma obtains marketing and manufacturing approval from the Japanese government for Steboronine for meningioma, the relevant China filings may also be extended to the meningioma indication.

2026-08-12

Russia Approves Chinese Academy of Sciences' Accession to International Research Organization at PIK Reactor

Russia Approves Chinese Academy of Sciences' Accession to International Research Organization at PIK Reactor

Mikhail Kovalchuk, Director of the Kurchatov Institute National Research Centre in Russia, recently stated that Russia has approved the Chinese Academy of Sciences' accession to the International Centre for Synchrotron Radiation, Neutron and Laser Research, which is being established around the PIK high-flux research reactor. Speaking at a meeting of the Science and Education Committee held in Novosibirsk, Kovalchuk said that three Chinese institutions have successively submitted applications to join the international organization, with the application from the Chinese Academy of Sciences having completed review and received approval. In June of this year, he had indicated that the Chinese side was interested in participating in this international research cooperation mechanism. The PIK high-flux research reactor is located in Gatchina, Russia, and was developed by the Konstantinov Petersburg Nuclear Physics Institute...

2026-08-12

Fujita Health University in Japan Advances Research on Expanding BNCT Indications for Deep-Seated Cancers, to Conduct 18F-FBPA PET Exploratory Evaluation

Fujita Health University in Japan Advances Research on Expanding BNCT Indications for Deep-Seated Cancers, to Conduct 18F-FBPA PET Exploratory Evaluation

On August 10, Stella Pharma Corporation of Japan announced that it is collaborating with Fujita Health University and other institutions to advance research and development aimed at expanding Boron Neutron Capture Therapy (BNCT) to deep-seated cancers. As part of this project, Stella Pharma will participate in an exploratory study on 18F-FBPA uptake capacity in deep-seated cancers conducted by Fujita Health University. The study will use 18F-FBPA PET to evaluate the tumor accumulation of boron drugs used in BNCT in deep-seated cancers, and based on the findings, explore the possibility of expanding BNCT indications in the future. The study plans to collect data from 50 cases, including pancreatic cancer, hepatocellular carcinoma, and biliary tract cancer, to accumulate foundational evidence needed for the development of BNCT for deep-seated cancers. BNC...

2026-08-11

International Team Measures Niobium-94 Neutron Reactions, Explaining Anomalous Molybdenum-94 Abundance in the Solar System

International Team Measures Niobium-94 Neutron Reactions, Explaining Anomalous Molybdenum-94 Abundance in the Solar System

An international team of physicists has, for the first time, conducted a comprehensive study of the interactions between neutrons and the niobium-94 isotope. The findings have been published in Physical Review Letters. The study suggests that the elevated abundance of molybdenum-94 in the primordial material of the solar system can be explained by a series of neutron-involving nuclear reaction processes inside old stars, without requiring the introduction of previously unknown special formation mechanisms. The research was led by Alberto Mengoni, a researcher at the Italian National Institute for Nuclear Physics. The team conducted experiments using the n_TOF facility at CERN, focusing on tracking the interactions between neutrons and niobium-94 atoms. The n_TOF facility is used to...

2026-08-11

228 Research Reactors Worldwide in Operation, Supporting Medical Isotope Production and Neutron Science Innovation

228 Research Reactors Worldwide in Operation, Supporting Medical Isotope Production and Neutron Science Innovation

According to the International Atomic Energy Agency on August 7, research reactors continue to drive innovation in science, medicine, and industry worldwide. Currently, 228 research reactors are in operation across 54 countries, with another 23 under construction or in the planning stage. Unlike nuclear reactors used for power generation, these reactors primarily produce neutrons to support medical, industrial, agricultural, geological, forensic, and nuclear science research. A research reactor pool photographed from above. (Photo: IAEA) In the medical field, research reactors are a vital source of medical radioisotopes. Among them, technetium-99m is widely used for diagnosing cancer and diseases of the heart, brain, and bones; a large number of medical diagnostic and therapeutic procedures worldwide rely on this isotope. Other radioisotopes such as iodine-131 are also used in the treatment of cancer and thyroid diseases. The IAEA states that radioisotopes produced by research reactors serve millions of patients globally and are an essential component of modern nuclear medicine systems.

2026-08-09